Q4 2019 Holdings
Filed 2020-02-13 | 23 holdings | $4.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals(CPIX) | COM | 230770109 | $4.6M | 896,170 | 97.1% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $33.3K | 1,551,300 | 0.7% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $25.7K | 3,000,000 | 0.5% |
| Affimed NV | COM | N01045108 | $11.0K | 4,010,155 | 0.2% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $10.5K | 630,862 | 0.2% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $8.5K | 2,241,239 | 0.2% |
| Neos Therapeutics Inc(NEOS) | COM NEW | 64052L106 | $7.3K | 4,858,889 | 0.2% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $5.9K | 3,755,000 | 0.1% |
| Xoma Corp(XOMA) | COM NEW | 98419J206 | $5.5K | 200,667 | 0.1% |
| Opiant Pharmaceuticals Inc | COM | 683750103 | $4.8K | 334,272 | 0.1% |
| Evolus Inc(EOLS) | COM | 30052C107 | $4.8K | 394,890 | 0.1% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $4.7K | 1,651,333 | 0.1% |
| HTG Molecular Diagnostics | COM | 40434H104 | $3.3K | 4,758,426 | 0.1% |
| Aegerion Pharmaceuticals Inc | NOTE 5.000% 4/0 | 00767EAC6 | $2.8K | 2,993,334 | 0.1% |
| Novelion Therapeutics Inc | COM | 67001K202 | $2.8K | 3,909,207 | 0.1% |
| Aptevo Therapeutics Inc | COM | 03835L108 | $2.7K | 4,179,131 | 0.1% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $2.1K | 307,287 | 0.0% |
| Chiasma Inc(CHMA) | COM | 16706W102 | $911 | 183,660 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $903 | 431,853 | 0.0% |
| Scynexis Inc | COM | 811292101 | $555 | 609,384 | 0.0% |
| Interpace Biosciences Inc | COM NEW | 46062X303 | $472 | 943,851 | 0.0% |
| Restorbio Inc | COM | 76133L103 | $122 | 81,772 | 0.0% |
| Acer Therapeutics Inc(OPXAEUR) | COM | 00444P108 | $80 | 20,000 | 0.0% |